Bell Palsy Treatment Market - Top Companies and Manufacturers

  • Report ID: 3500
  • Published Date: Mar 04, 2024
  • Report Format: PDF, PPT

Top Featured Companies Dominating the Bell’s Palsy Treatment Landscape

    • Astellas Pharma Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • tVns Technologies Gmbh
    • Novartis AG
    • Sanofi-Aventis Groupe
    • Abbott Laboraties
    • Merck & Co., Inc.
    • Siemens Healthcare GmbH.
    • Pfizer Inc.
    • Eli Lilly and Company.
    • BioControl Medical.

Browse Key Market Insights with Data Illustration:

In the News

21 July, 2020: Surgeons at UT Southwestern have developed a cutting-edge technique for Bell’s Palsy patients, enabling effective eye closure and corneal protection. Detailed in a 2020 journal article, the procedure involves a sophisticated approach that reinnervates eye muscles, ensuring faster and more complete closure. It’s most beneficial for patients with paralysis for under 18 months. The research conducted by UT Southwestern team has demonstrated that patients undergoing this procedure experience faster and more complete eye closure, leading to enhanced protection of the cornea. This innovation represents a significant advancement in Bell’s palsy treatment, underscoring UT Southwestern’s commitment to pioneering research and clinical excellence in reconstructive surgery.

April 27, 2023: Research in JAMA Otolaryngology – Head and Neck surgery compared Bell’s palsy incidence in Cvoid-19 vaccine recipients to unvaccinated or placebo groups. While incidence was higher among vaccinated individuals in randomized trails, no association was found in observational studies. Additionally, bell’s palsy was more common during CVOID-19infecion than after vaccination, with significant increase in risk compared to SARS-CoV-2 vaccines. Furthermore, more research is required to verify the results so far and also understand why some individuals develop Bell’s palsy after vaccination.


Author Credits:  Radhika Pawar


  • Report ID: 3500
  • Published Date: Mar 04, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing prevalence of viral infection due to poor immunity, unhealthy lifestyle, advancements in medical and technological aspects of bell's palsy treatment is estimated to boost the market growth.

The market size of Bell ’s palsy treatment is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are BOSTON SCIENTIFIC, BIOCONTROL Medical, Novartis AG and others.

The medication segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample